TAKHZYRO now available in Newfoundland & Labrador
daphnecanada2021-05-03T15:14:46-06:00We love sharing amazing news, and now we have even more to love! On March 17th, 2021, lanadelumab (TAKHZYRO), a subcutaneous monoclonal antibody inhibitor of plasma kallikrein, was added to the Newfoundland & Labrador Prescription